Glucagon-like peptides 1 and 2 in health and disease: A review
dc.contributor.author | Marathe, C. | |
dc.contributor.author | Rayner, C. | |
dc.contributor.author | Jones, K. | |
dc.contributor.author | Horowitz, M. | |
dc.date.issued | 2013 | |
dc.description.abstract | The gut derived peptides, glucagon-like peptides 1 and 2 (GLP-1 and GLP-2), are secreted following nutrient ingestion. GLP-1 and another gut peptide, glucose-dependent insulinotropic polypeptide (GIP) are collectively referred to as 'incretin' hormones, and play an important role in glucose homeostasis. Incretin secretion shares a complex interdependent relationship with both postprandial glycemia and the rate of gastric emptying. GLP-1 based therapies are now well established in the management of type 2 diabetes, while recent literature has suggested potential applications to treat obesity and protect against cardiovascular and neurological disease. The mechanism of action of GLP-2 is not well understood, but it shows promise as an intestinotropic agent. | |
dc.description.statementofresponsibility | Chinmay S. Marathe, Christopher K. Rayner, Karen L. Jones, Michael Horowitz | |
dc.identifier.citation | Peptides, 2013; 44:75-86 | |
dc.identifier.doi | 10.1016/j.peptides.2013.01.014 | |
dc.identifier.issn | 0196-9781 | |
dc.identifier.issn | 1873-5169 | |
dc.identifier.orcid | Rayner, C. [0000-0002-5527-256X] | |
dc.identifier.orcid | Jones, K. [0000-0002-1155-5816] | |
dc.identifier.orcid | Horowitz, M. [0000-0002-0942-0306] | |
dc.identifier.uri | http://hdl.handle.net/2440/80360 | |
dc.language.iso | en | |
dc.publisher | Elsevier Science Inc | |
dc.rights | © 2013 Elsevier Inc. All rights reserved. | |
dc.source.uri | http://www.sciencedirect.com/science/article/pii/S0196978113000338 | |
dc.subject | Pancreas | |
dc.subject | Animals | |
dc.subject | Humans | |
dc.subject | Diabetes Mellitus, Type 2 | |
dc.subject | Blood Glucose | |
dc.subject | Receptors, Glucagon | |
dc.subject | Gastric Emptying | |
dc.subject | Postprandial Period | |
dc.subject | Glucagon-Like Peptide 1 | |
dc.subject | Glucagon-Like Peptide 2 | |
dc.subject | Clinical Trials as Topic | |
dc.subject | Incretins | |
dc.title | Glucagon-like peptides 1 and 2 in health and disease: A review | |
dc.type | Journal article | |
pubs.publication-status | Published |